Ivabradine in refractory neonatal ectopic atrial tachycardia: expanding therapeutic options in early life

Cardiology in the Young 2026 Open access

Read full text
Authors: Marcos Clavero Adell, Francisco Contreras‐Chova, Enrique Blanca-Jover
DOI: 10.1017/s104795112612352x
Cited by: 1
References: 7

Abstract

Neonatal ectopic atrial tachycardia is a rare arrhythmia that may be resistant to conventional therapy. We report a neonate with persistent foetal tachycardia refractory to flecainide and digoxin. Ivabradine resulted in rapid and sustained heart rate reduction without haemodynamic compromise. This case supports ivabradine as a therapeutic option in neonatal automatic tachycardias when standard treatments fail.

Fields of Study & Subjects

Cardiac Arrhythmias and Treatments Heart rate and cardiovascular health Cardiovascular Syncope and Autonomic Disorders

Publication details

Journal / source
Cardiology in the Young
Publisher
Cambridge University Press (CUP)
Volume
36
Issue
7
Pages
1–3
Publication date
17 July 2026
Language
EN